Oaktree Acquisition Corp. III Life Sciences (OACC) Change in Accured Expenses (2025)

Oaktree Acquisition Corp. III Life Sciences (OACC) reported Change in Accured Expenses of -$90000.0 for Q4 2025, down 240.68% quarter-over-quarter from $63977.0 in Q3 2025.

Oaktree Acquisition Corp. III Life Sciences (OACC) Change in Accured Expenses (2025) Analysis & Trends

Oaktree Acquisition Corp. III Life Sciences has reported Change in Accured Expenses for 1 years, with the latest figure at -$90000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses changed N/A year-over-year to -$90000.0; the trailing twelve-month figure through Mar 2026 stood at -$40155.0 (changed N/A YoY), and the FY2025 full-year result was -$179984.0, down 133.61% from the prior year.
  • Change in Accured Expenses for Q4 2025 stood at -$90000.0, down from $63977.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $63977.0 in Q3 2025, with the low at -$139829.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - 112,542.00
2 Berto Acquisition 312.46 Mn 312.46 Mn - 82,500.00
3 Centurion Acquisition 311.65 Mn 311.65 Mn - 95,385.00
4 GP-Act III Acquisition 311.36 Mn 311.36 Mn - 22,036.00
5 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - 772,181.00
6 WEN Acquisition 309.15 Mn 309.15 Mn - -13,704.00
7 Bold Eagle Acquisition 275.54 Mn 275.54 Mn - 46,445.00
8 Soulpower Acquisition 264.91 Mn 264.91 Mn - 437,800.00
9 BTC Development 262.16 Mn 262.16 Mn - 28,266.00
10 Oaktree Acquisition Corp. III Life Sciences 57.34 Mn 57.34 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -90,000.00
Dec 31, 2025 -90,000.00
Sep 30, 2025 63,977.00
Sep 30, 2025 63,977.00
Jun 30, 2025 -14,132.00
Jun 30, 2025 -14,132.00
Mar 31, 2025 -139,829.00
Mar 31, 2025 -139,829.00